These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Chemotherapy of leprosy: progress since the Orlando Congress, and prospects for the future. Ji B, Levy L, Grosset JH. Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S80-8; discussion S88-90. PubMed ID: 9030133 [No Abstract] [Full Text] [Related]
52. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity. Shaw IN, Christian M, Jesudasan K, Kurian N, Rao GS. Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255 [Abstract] [Full Text] [Related]
55. Single-dose ROM treatment for multilesion paucibacillary leprosy--further observations. Revankar CR, Bulchand HO, Pai VV, Ganapati R. Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):37-8. PubMed ID: 12120040 [No Abstract] [Full Text] [Related]
56. Six months MDT for paucibacillary leprosy: nerve damage and relapse. Wheate HW. Lepr Rev; 1986 Jun; 57(2):179. PubMed ID: 3747708 [No Abstract] [Full Text] [Related]
57. Leprosy at a turning point? Harboe M. Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):312-8. PubMed ID: 11221095 [No Abstract] [Full Text] [Related]